These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

592 related items for PubMed ID: 14743508

  • 1. BRAF mutations are associated with some histological types of papillary thyroid carcinoma.
    Trovisco V, Vieira de Castro I, Soares P, Máximo V, Silva P, Magalhães J, Abrosimov A, Guiu XM, Sobrinho-Simões M.
    J Pathol; 2004 Feb; 202(2):247-51. PubMed ID: 14743508
    [Abstract] [Full Text] [Related]

  • 2. BRAF mutations in an Italian cohort of thyroid cancers.
    Fugazzola L, Mannavola D, Cirello V, Vannucchi G, Muzza M, Vicentini L, Beck-Peccoz P.
    Clin Endocrinol (Oxf); 2004 Aug; 61(2):239-43. PubMed ID: 15272920
    [Abstract] [Full Text] [Related]

  • 3. A new BRAF gene mutation detected in a case of a solid variant of papillary thyroid carcinoma.
    Trovisco V, Soares P, Soares R, Magalhães J, Sá-Couto P, Sobrinho-Simões M.
    Hum Pathol; 2005 Jun; 36(6):694-7. PubMed ID: 16021577
    [Abstract] [Full Text] [Related]

  • 4. BRAF mutation associated with other genetic events identifies a subset of aggressive papillary thyroid carcinoma.
    Costa AM, Herrero A, Fresno MF, Heymann J, Alvarez JA, Cameselle-Teijeiro J, García-Rostán G.
    Clin Endocrinol (Oxf); 2008 Apr; 68(4):618-34. PubMed ID: 18070147
    [Abstract] [Full Text] [Related]

  • 5. BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC.
    Soares P, Trovisco V, Rocha AS, Lima J, Castro P, Preto A, Máximo V, Botelho T, Seruca R, Sobrinho-Simões M.
    Oncogene; 2003 Jul 17; 22(29):4578-80. PubMed ID: 12881714
    [Abstract] [Full Text] [Related]

  • 6. BRAF(V599E) mutation is the leading genetic event in adult sporadic papillary thyroid carcinomas.
    Puxeddu E, Moretti S, Elisei R, Romei C, Pascucci R, Martinelli M, Marino C, Avenia N, Rossi ED, Fadda G, Cavaliere A, Ribacchi R, Falorni A, Pontecorvi A, Pacini F, Pinchera A, Santeusanio F.
    J Clin Endocrinol Metab; 2004 May 17; 89(5):2414-20. PubMed ID: 15126572
    [Abstract] [Full Text] [Related]

  • 7. High prevalence of BRAF gene mutation in papillary thyroid carcinomas and thyroid tumor cell lines.
    Xu X, Quiros RM, Gattuso P, Ain KB, Prinz RA.
    Cancer Res; 2003 Aug 01; 63(15):4561-7. PubMed ID: 12907632
    [Abstract] [Full Text] [Related]

  • 8. Genotyping of an Italian papillary thyroid carcinoma cohort revealed high prevalence of BRAF mutations, absence of RAS mutations and allowed the detection of a new mutation of BRAF oncoprotein (BRAF(V599lns)).
    Carta C, Moretti S, Passeri L, Barbi F, Avenia N, Cavaliere A, Monacelli M, Macchiarulo A, Santeusanio F, Tartaglia M, Puxeddu E.
    Clin Endocrinol (Oxf); 2006 Jan 01; 64(1):105-9. PubMed ID: 16402937
    [Abstract] [Full Text] [Related]

  • 9. Type and prevalence of BRAF mutations are closely associated with papillary thyroid carcinoma histotype and patients' age but not with tumour aggressiveness.
    Trovisco V, Soares P, Preto A, de Castro IV, Lima J, Castro P, Máximo V, Botelho T, Moreira S, Meireles AM, Magalhães J, Abrosimov A, Cameselle-Teijeiro J, Sobrinho-Simões M.
    Virchows Arch; 2005 Jun 01; 446(6):589-95. PubMed ID: 15902486
    [Abstract] [Full Text] [Related]

  • 10. Correlation between B-RAFV600E mutation and clinico-pathologic parameters in papillary thyroid carcinoma: data from a multicentric Italian study and review of the literature.
    Fugazzola L, Puxeddu E, Avenia N, Romei C, Cirello V, Cavaliere A, Faviana P, Mannavola D, Moretti S, Rossi S, Sculli M, Bottici V, Beck-Peccoz P, Pacini F, Pinchera A, Santeusanio F, Elisei R.
    Endocr Relat Cancer; 2006 Jun 01; 13(2):455-64. PubMed ID: 16728573
    [Abstract] [Full Text] [Related]

  • 11. Correlation between BRAF mutation and the clinicopathological parameters in papillary thyroid carcinoma with particular reference to follicular variant.
    Smith RA, Salajegheh A, Weinstein S, Nassiri M, Lam AK.
    Hum Pathol; 2011 Apr 01; 42(4):500-6. PubMed ID: 21167555
    [Abstract] [Full Text] [Related]

  • 12. BRAF mutations typical of papillary thyroid carcinoma are more frequently detected in undifferentiated than in insular and insular-like poorly differentiated carcinomas.
    Soares P, Trovisco V, Rocha AS, Feijão T, Rebocho AP, Fonseca E, Vieira de Castro I, Cameselle-Teijeiro J, Cardoso-Oliveira M, Sobrinho-Simões M.
    Virchows Arch; 2004 Jun 01; 444(6):572-6. PubMed ID: 15095090
    [Abstract] [Full Text] [Related]

  • 13. Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations.
    Quiros RM, Ding HG, Gattuso P, Prinz RA, Xu X.
    Cancer; 2005 Jun 01; 103(11):2261-8. PubMed ID: 15880523
    [Abstract] [Full Text] [Related]

  • 14. [Molecular analysis of structural abnormalities in papillary thyroid carcinoma gene].
    Vasil'ev EV, Rumiantsev PO, Saenko VA, Il'in AA, Poliakova EIu, Nemtsova MV, Zaletaev DV.
    Mol Biol (Mosk); 2004 Jun 01; 38(4):642-53. PubMed ID: 15456136
    [Abstract] [Full Text] [Related]

  • 15. High prevalence of B-RAF mutation in papillary carcinoma of the thyroid in north-east Italy.
    Girlando S, Cuorvo LV, Bonzanini M, Morelli L, Amadori P, Dalla Palma P, Barbareschi M.
    Int J Surg Pathol; 2010 Jun 01; 18(3):173-6. PubMed ID: 20460314
    [Abstract] [Full Text] [Related]

  • 16. [BRAFV599E mutation and RET/PTC rearrangements in papillary thyroid carcinoma].
    Zhu XL, Zhou XY, Zhu XZ.
    Zhonghua Bing Li Xue Za Zhi; 2005 May 01; 34(5):270-4. PubMed ID: 16181547
    [Abstract] [Full Text] [Related]

  • 17. Detection of BRAF V600E mutation in thyroid fine-needle aspiration specimens by High Resolution Melting (HRM) analysis.
    Nechifor-Boilă A, Decaussin-Petrucci M, Gazzo S, Paşcanu I, Borda A.
    Rom J Morphol Embryol; 2012 May 01; 53(2):263-7. PubMed ID: 22732794
    [Abstract] [Full Text] [Related]

  • 18. Different structural components of conventional papillary thyroid carcinoma display mostly identical BRAF status.
    Abrosimov A, Saenko V, Rogounovitch T, Namba H, Lushnikov E, Mitsutake N, Yamashita S.
    Int J Cancer; 2007 Jan 01; 120(1):196-200. PubMed ID: 17044028
    [Abstract] [Full Text] [Related]

  • 19. BRAF (V600E) mutation analysis on liquid-based cytology-processed aspiration biopsies predicts bilaterality and lymph node involvement in papillary thyroid microcarcinoma.
    Rossi ED, Martini M, Capodimonti S, Lombardi CP, Pontecorvi A, Vellone VG, Zannoni GF, Larocca LM, Fadda G.
    Cancer Cytopathol; 2013 Jun 01; 121(6):291-7. PubMed ID: 23192956
    [Abstract] [Full Text] [Related]

  • 20. No correlation between BRAFV600E mutation and clinicopathological features of papillary thyroid carcinomas in Taiwan.
    Liu RT, Chen YJ, Chou FF, Li CL, Wu WL, Tsai PC, Huang CC, Cheng JT.
    Clin Endocrinol (Oxf); 2005 Oct 01; 63(4):461-6. PubMed ID: 16181240
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.